The C1431T polymorphism of peroxisome proliferator activated receptor γ ( PPARγ) is associated with low risk of diabetes in a Pakistani cohort

被引:10
|
作者
Butt, Huma [1 ]
Shabana [1 ]
Hasnain, Shahida [1 ,2 ]
机构
[1] Univ Punjab, Dept Microbiol & Mol Genet, Lahore, Pakistan
[2] Women Univ Multan, Multan, Pakistan
来源
关键词
Diabetes; C1431T; Peroxisome proliferators-activated receptor; Pakistan; SERUM-LIPID LEVELS; BLOOD-LIPIDS; GENETIC-VARIANTS; PRO12ALA; OBESITY; SUSCEPTIBILITY; PPAR-GAMMA-2; HAPLOTYPES; AMERICANS; DISEASE;
D O I
10.1186/s13098-016-0183-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Diabetes is a socioeconomic burden in Pakistan. International diabetes federation reported 6.9 million cases of diabetes and 87,548 deaths due to diabetes in Pakistan in 2014. Peroxisome proliferators-activated receptors are transcription factors, regulating several physiological processes. Aim: The aim of the current study was to determine the prevalence of silent variant C1431T in exon 6 of PPAR-y and analyze its effect on various anthropometric and biochemical parameters in a Pakistani cohort. Methods: We collected 926 samples, 500 healthy controls (fasting blood sugar < 99 mg/dL, random blood sugar < 126 mg/dL) and 426 cases with diabetes (fasting blood sugar > 99 mg/dL, random blood sugar > 126 mg/dL). The genotyping was done by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) and serum biochemical parameters were determined by commercially available kits. Results: The genotyping results by RLFP showed allelic frequency C = 61.2 % and T = 38.8 % in controls while C = 74.5 % and T = 25.5 % in cases (OR 0.536, CI 0.439-0.655, p = 8.2 x 10(-10)) and genotypic frequency CC = 38.8 %, CT = 44.7 %, TT = 16.5 % in controls. While CC = 53.6 %, CT = 41.4 %, TT = 5.1 % in cases (OR 0.544, CI 0.408-0.726, p = 2.3 x 10(-10)). The rare T allele appeared to be a protective allele i.e., the presence of rare allele lowered the risk of diabetes in the studied cohort. The biochemical and anthropometric parameters were analyzed for any significant association with the SNP showing that C1431T variant has an association with BMI, weight, fasting glucose and LDLC. However, no significant association was found with age, gender, height, HDLC, TC, triglycerides and leptin. Conclusion: In conclusion, the presence of minor allele lowers the risk of diabetes and the effect may involve modulating certain serum parameters.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Differential effects of the C1431T and Pro12Ala PPARγ gene variants on plasma lipids and diabetes risk in an Asian population
    Tai, ES
    Corella, D
    Deurenberg-Yap, M
    Adiconis, X
    Chew, SK
    Tan, CE
    Ordovas, JM
    JOURNAL OF LIPID RESEARCH, 2004, 45 (04) : 674 - 685
  • [42] Polymorphism of peroxisome proliferator-activated receptor gamma is not associated to Japanese ulcerative colitis
    Wang, Fangyu
    Tahara, Tomomitsu
    Arisawa, Tomiyasu
    Sakata, Mikijyu
    Takahama, Kazuya
    Watanabe, Makoto
    Hirata, Ichiro
    Nakano, Hiroshi
    HEPATO-GASTROENTEROLOGY, 2008, 55 (81) : 73 - 75
  • [43] Peroxisome proliferator-activated receptor (PPAR)-α activation prevents diabetes in OLETF rats -: Comparison with PPAR-γ activation
    Koh, EH
    Kim, MS
    Park, JY
    Kim, HS
    Youn, JY
    Park, HS
    Youn, JH
    Lee, KU
    DIABETES, 2003, 52 (09) : 2331 - 2337
  • [44] Discovery of a Peroxisome Proliferator Activated Receptor γ (PPARγ) Modulator with Balanced PPARα Activity for the Treatment of Type 2 Diabetes and Dyslipidemia
    Liu, Weiguo
    Liu, Kun
    Wood, Harold B.
    McCann, Margaret E.
    Doebber, Thomas W.
    Chang, Ching H.
    Akiyama, Taro E.
    Einstein, Monica
    Berger, Joel P.
    Meinke, Peter T.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (14) : 4443 - 4453
  • [45] Peroxisome proliferator activated receptor polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes mellitus
    Herrmann, SM
    Ringel, J
    Wang, JG
    Staessen, JA
    Brand, E
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R115 - R115
  • [46] Peroxisome proliferator activated receptor polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes mellitus
    Herrmann, SM
    Ringel, J
    Wang, JG
    Staessen, JA
    Brand, E
    JOURNAL OF HYPERTENSION, 2002, 20 : S26 - S26
  • [47] Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes
    Pollex, Rebecca L.
    Mamakeesick, Mary
    Zinman, Bernard
    Harris, Stewart B.
    Hegele, Robert A.
    Hanley, Anthony J. G.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2007, 21 (03) : 166 - 171
  • [48] Peroxisome proliferator-activated receptor-alpha (PPARα): At the crossroads of obesity, diabetes and cardiovascular disease
    Fruchart, Jean-Charles
    ATHEROSCLEROSIS, 2009, 205 (01) : 1 - 8
  • [49] Association of bone mineral density with a polymorphism of the peroxisome proliferator-activated receptor γ gene:: PPARγ expression in osteoblasts
    Ogawa, S
    Urano, T
    Hosoi, T
    Miyao, M
    Hoshino, S
    Fujita, M
    Shiraki, M
    Orimo, H
    Ouchi, Y
    Inoue, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 260 (01) : 122 - 126
  • [50] The C161T polymorphism of peroxisome proliferator-activated receptor gamma gene is associated with the occurrence and severity of coronary artery disease
    Chao, TH
    Li, YH
    Chan, SH
    Chen, JH
    Wu, HL
    Shi, GY
    Tsai, LM
    Lin, LJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 196A - 196A